1. Home
  2. HALO vs EXP Comparison

HALO vs EXP Comparison

Compare HALO & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • EXP
  • Stock Information
  • Founded
  • HALO 1998
  • EXP 1963
  • Country
  • HALO United States
  • EXP United States
  • Employees
  • HALO N/A
  • EXP N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • EXP Building Materials
  • Sector
  • HALO Health Care
  • EXP Industrials
  • Exchange
  • HALO Nasdaq
  • EXP Nasdaq
  • Market Cap
  • HALO 7.4B
  • EXP 7.3B
  • IPO Year
  • HALO N/A
  • EXP 1994
  • Fundamental
  • Price
  • HALO $66.58
  • EXP $239.49
  • Analyst Decision
  • HALO Buy
  • EXP Buy
  • Analyst Count
  • HALO 9
  • EXP 11
  • Target Price
  • HALO $63.78
  • EXP $275.45
  • AVG Volume (30 Days)
  • HALO 2.1M
  • EXP 291.8K
  • Earning Date
  • HALO 05-06-2025
  • EXP 05-20-2025
  • Dividend Yield
  • HALO N/A
  • EXP 0.42%
  • EPS Growth
  • HALO 55.40
  • EXP N/A
  • EPS
  • HALO 3.76
  • EXP 13.93
  • Revenue
  • HALO $1,084,306,000.00
  • EXP $2,267,040,000.00
  • Revenue This Year
  • HALO $20.06
  • EXP $1.58
  • Revenue Next Year
  • HALO $24.20
  • EXP $4.92
  • P/E Ratio
  • HALO $17.71
  • EXP $17.20
  • Revenue Growth
  • HALO 25.64
  • EXP 0.64
  • 52 Week Low
  • HALO $41.28
  • EXP $201.61
  • 52 Week High
  • HALO $70.51
  • EXP $321.93
  • Technical
  • Relative Strength Index (RSI)
  • HALO 60.23
  • EXP 61.98
  • Support Level
  • HALO $58.38
  • EXP $222.36
  • Resistance Level
  • HALO $69.94
  • EXP $232.98
  • Average True Range (ATR)
  • HALO 2.71
  • EXP 7.01
  • MACD
  • HALO 0.84
  • EXP 1.55
  • Stochastic Oscillator
  • HALO 69.44
  • EXP 91.92

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

Share on Social Networks: